Overall Survival with Combined Nivolumab and Ipilimumab in Advanced Melanoma

Memorial Sloan Kettering Cancer Center, Cornell University, University of Padua, University of Colorado Denver, The Maria Sklodowska-Curie National Research Institute of Oncology, Aix-Marseille Université, Hôpital de la Timone, Texas Oncology, University of Michigan, Swansea University, German Cancer Research Center, Deutschen Konsortium für Translationale Krebsforschung, Mylan (Switzerland), European Institute of Oncology, Cancer Institute (WIA), See-Spital, Trans Tasman Radiation Oncology Group, Princess Margaret Cancer Centre, The Netherlands Cancer Institute, Melanoma Institute Australia, The University of Sydney, KU Leuven, University of Siena, Hospital General Universitario Gregorio Marañón, Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori, Istituti di Ricovero e Cura a Carattere Scientifico, Peter MacCallum Cancer Centre, Université Paris Cité, Délégation Paris 7, Inserm, Hôpital Saint-Louis, Assistance Publique – Hôpitaux de Paris, Istituto Nazionale Tumori IRCCS "Fondazione G. Pascale", The University of Melbourne, Olivia Newton-John Cancer Wellness & Research Centre, Northwestern University, Bristol-Myers Squibb (United States), Dana-Farber Cancer Institute, Royal Marsden NHS Foundation Trust